Patents by Inventor Demetrius Maraganore

Demetrius Maraganore has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070161595
    Abstract: Aspects featured in the invention relate to compositions and methods for inhibiting alpha-synuclein (SNCA) gene expression, such as for the treatment of neurodegenerative disorders. An anti-SNCA agent featured herein that targets the SNCA gene can have been modified to alter distribution in favor of neural cells.
    Type: Application
    Filed: October 12, 2006
    Publication date: July 12, 2007
    Applicants: Mayo Foundation for Medical Education and Research, Alnylam Pharmaceuticals, Inc.
    Inventors: David Bumcrot, Matthew Farrer, Demetrius Maraganore, Hans-Peter Vornlocher
  • Publication number: 20070092889
    Abstract: Compositions and methods for use in the therapeutic and preventative treatment, study, diagnosis and prognosis of PD-related disease are disclosed. Also provided are kits and reagents for prognosis and diagnosis of PD-related disease and related conditions.
    Type: Application
    Filed: June 2, 2006
    Publication date: April 26, 2007
    Applicant: Perlegen Sciences, Inc.
    Inventors: David Cox, Demetrius Maraganore, Dennis Ballinger, Krishna Pant, Timothy Lesnick
  • Publication number: 20050186591
    Abstract: Aspects featured in the invention relate to compositions and methods for inhibiting alpha-synuclein (SNCA) gene expression, such as for the treatment of neurodegenerative disorders. An anti-SNCA agent featured herein that targets the SNCA gene can have been modified to alter distribution in favor of neural cells.
    Type: Application
    Filed: November 17, 2004
    Publication date: August 25, 2005
    Inventors: David Bumcrot, Matthew Farrer, Demetrius Maraganore, Hans-Peter Vornlocher